Mercury Securities
  • Try MST28 trading from Mercury Securities with rates as low as 0.05%.
  • Earn MS Coin when you trade with MST28. Check out MST28.
  • Try MST28 trading from Mercury Securities with rates as low as 0.05%.
  • Get FREE real time quotes on our website & App. Check out MST28.
Open Trading Account
add free Download App
premium Premium Account

Last Price Change Volume
Open: Day Range: Prev Close:


MEMORANDUM OF UNDERSTANDING Bintai Kinden Corporation Berhad ("BKCB" or "Company") - Status Update on the Memorandum of Understanding between Bintai Healthcare Sdn Bhd and Generex Biotechnology Corporation and NuGenerex Immuno-Oncology Inc. (Collectively referred to as Generex)

BINTAI KINDEN CORPORATION BERHAD

Type Announcement
Subject MEMORANDUM OF UNDERSTANDING
Description
Bintai Kinden Corporation Berhad ("BKCB" or "Company")
- Status Update on the Memorandum of Understanding between Bintai Healthcare Sdn Bhd and Generex Biotechnology Corporation and NuGenerex Immuno-Oncology Inc. (Collectively referred to as Generex)

We refer to our announcements dated 25 November 2020, 6 July 2021, 6 October 2021 in relation to the Memorandum of Understanding (“MOU”) entered into between Bintai Healthcare Sdn Bhd [Registration No. 202001027986 (1384306-P) (“BHSB”), a 50.05% owned subsidiary of the Company, and Generex for the proposed sole distribution rights for BHSB to market and supply the synthetic peptide vaccine for SARS-CoV-2 Coronavirus Vaccine to the Australia and New Zealand markets.

 

The Board of Directors of BKCB wishes to announce that as of todate, the MOU on the above matter remain status quo and any further development thereon shall be announced in due course.

 

This announcement is dated 6 January 2022.






Announcement Info

Company Name BINTAI KINDEN CORPORATION BERHAD
Stock Name BINTAI
Date Announced 06 Jan 2022
Category General Announcement for PLC
Reference Number GA1-06012022-00022




Close